Here are the latest quarterly results of GUJARAT NARMADA. For more details, see the GUJARAT NARMADA financial fact sheet and GUJARAT NARMADA share price and chart.
No. of Mths Qtr. Ending |
3
Jun-20* |
3
Sep-20* |
3
Dec-20* |
3
Mar-21* |
3
Jun-21* |
3
Sep-21* |
3
Dec-21* |
3
Mar-22* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 7,002 | 11,872 | 15,082 | 17,330 | 13,943 | 20,959 | 23,803 | 27,717 | |
Other income | Rs m | 1,039 | 394 | 448 | 492 | 429 | 577 | 482 | 606 | |
Turnover | Rs m | 8,041 | 12,265 | 15,530 | 17,822 | 14,373 | 21,536 | 24,285 | 28,324 | |
Expenses | Rs m | 7,245 | 9,930 | 11,453 | 12,626 | 10,012 | 16,651 | 17,064 | 18,858 | |
Gross profit | Rs m | -243 | 1,942 | 3,630 | 4,704 | 3,931 | 4,309 | 6,739 | 8,859 | |
Depreciation | Rs m | 660 | 681 | 697 | 685 | 697 | 709 | 767 | 744 | |
Interest | Rs m | 117 | 60 | 9 | 13 | 8 | 8 | 11 | 8 | |
Profit before tax | Rs m | 19 | 1,595 | 3,371 | 4,498 | 3,655 | 4,169 | 6,443 | 8,713 | |
Tax | Rs m | 4 | 208 | 970 | 1,409 | 1,257 | 1,346 | 1,059 | 2,281 | |
Profit after tax | Rs m | 15 | 1,387 | 2,401 | 3,089 | 2,399 | 2,823 | 5,383 | 6,433 | |
Gross profit margin | % | -3.5 | 16.4 | 24.1 | 27.1 | 28.2 | 20.6 | 28.3 | 32.0 | |
Effective tax rate | % | 22.7 | 13.0 | 28.8 | 31.3 | 34.4 | 32.3 | 16.4 | 26.2 | |
Net profit margin | % | 0.2 | 11.7 | 15.9 | 17.8 | 17.2 | 13.5 | 22.6 | 23.2 | |
Diluted EPS | Rs | 0.1 | 8.9 | 15.4 | 19.9 | 15.4 | 18.2 | 34.6 | 41.4 | |
Diluted EPS (TTM) | Rs | 27.9 | 31.6 | 39.8 | 44.3 | 59.7 | 68.9 | 88.1 | 109.6 | |
![]() |
Indian share markets witnessed a volatile trading session today as crude oil prices rebounded following last week's rout.
Top 5 fertiliser stocks that need to be in your watchlist for 2022.
Shares of Ami Organics makes a strong debut on the stock exchange. Did you bid for the IPO?
The grey market had indicated a flat listing for shares of Chemplast Sanmar ahead of its debut.
Will the pharma unit's demerger unlock value for shareholders?
What's the outlook for Devyani, Zomato, and Tatva Chintan Pharma after robust listings?
More Views on NewsWith India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.
Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.
Some sectors have corrected by 50%. Do they merit a look?
This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.
This is how you can tell the market is going to recover.
More